Consistent with our observations, two recent reports by Kettle et al. and Petrocchi et al. independently showed that different classes of MTH1 inhibitors with sub-nanomolar potency inhibited neither proliferation nor survival of human cancer cell line panels39, 40. This evidence concerns the gene NUDT1 and cancer.